Fujipream Corporation
Fujipream Corporation (4237.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Fujipream Corporation (4237.T), covering cash flow, earnings, and balance sheets.
Fujipream Corporation (4237.T) Income Statement & Financial Overview
Analyze Fujipream Corporation’s 4237.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.25B | $2.71B | $3.08B | $2.58B |
| Cost of Revenue | $1.75B | $2.44B | $2.70B | $2.25B |
| Gross Profit | $501.05M | $271.00M | $380.00M | $332.86M |
| Gross Profit Ratio | $0.22 | $0.10 | $0.12 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $352.65M | $304.00M | $307.00M | $301.00M |
| Operating Expenses | $352.65M | $304.00M | $307.00M | $302.00M |
| Total Costs & Expenses | $2.11B | $2.74B | $3.008B | $2.55B |
| Interest Income | $2.95M | $200000.00 | $4.02M | $1.00M |
| Interest Expense | $7.38M | $4.80M | $0.00 | $0.00 |
| Depreciation & Amortization | $135.31M | $131.25M | $125.50M | $131.25M |
| EBITDA | $276.57M | $98.25M | $198.50M | $163.25M |
| EBITDA Ratio | $0.12 | $0.04 | $0.06 | $0.06 |
| Operating Income | $148.40M | -$33.00M | $73.00M | $31.00M |
| Operating Income Ratio | $0.07 | -$0.01 | $0.02 | $0.01 |
| Other Income/Expenses (Net) | $1.53M | $251.00M | $4.00M | $8.00M |
| Income Before Tax | $149.94M | $218.00M | $77.00M | $39.00M |
| Income Before Tax Ratio | $0.07 | $0.08 | $0.02 | $0.02 |
| Income Tax Expense | $71.65M | $73.00M | $47.00M | $30.00M |
| Net Income | $78.28M | $145.00M | $30.00M | $9.00M |
| Net Income Ratio | $0.03 | $0.05 | $0.010 | $0.003 |
| EPS | $2.73 | $5.07 | $1.05 | $0.31 |
| Diluted EPS | $2.73 | $5.07 | $1.05 | $0.31 |
| Weighted Avg Shares Outstanding | $28.57M | $28.57M | $28.57M | $28.57M |
| Weighted Avg Shares Outstanding (Diluted) | $28.57M | $28.57M | $28.57M | $28.57M |
Financial performance has remained strong, with revenue growing from $2.58B in Q1 2024 to $2.25B in Q4 2024. Gross profit continued to perform well, with margins at 22% in the latest quarter. Operating income reached $148.40M in Q4 2024, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $276.57M. Net income dropped to $78.28M, keeping EPS at $2.73. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan